✦ LIBER ✦

Y chromosome evidence for a founder effect in Ashkenazi Jews

✍ Scribed by Nebel, Almut; Filon, Dvora; Faerman, Marina; Soodyall, Himla; Oppenheim, Ariella

Book ID: 110026124
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 87 KB
Volume: 13
Category: Article
ISSN: 1018-4813
DOI: 10.1038/sj.ejhg.5201319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and screening implications of t

Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia : Evidence for a founder effect

✍ Paul Rozen; Tova Naiman; Hana Strul; Philipp Taussky; Nataly Karminsky; Ruth Sho 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND The authors previously found the I1307K adenomatous polyposis coli (__APC__) gene variant in 5% of Ashkenazi control participants, in 15.4% of those who had familial colorectal neoplasia, but also in 1.6% of non‐Ashkenazi control participants. In this study, they evaluate

No Evidence for a Y Chromosomal Effect o

No Evidence for a Y Chromosomal Effect on Alternative Behavioral Strategies in Mice

✍ Frans Sluyter; Abel Bult; Carol B. Lynch; Feijo Meeter; Geert A. van Oortmerssen 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 702 KB

A major Y-chromosome haplogroup R1b Holo

A major Y-chromosome haplogroup R1b Holocene era founder effect in Central and Western Europe

✍ Myres, Natalie M; Rootsi, Siiri; Lin, Alice A; Järve, Mari; King, Roy J; Kutuev, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 852 KB

The frequency of founder mutations in th

The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in australian Ashkenazi Jews : Implications for the generality of u.s. population data

✍ Anita Y. Bahar; Peter J. Taylor; Lesley Andrews; Anne Proos; Leslie Burnett; Kat 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

A recurrent F8 mutation in Irish haemoph

A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect

✍ P. C. WINTER; H. EGAN; O. MCNULTY; F. G. C. JONES; J. O’DONNELL; P. V. JENKINS 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB

Molecular genetic evidence for a founder

Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians

✍ Christine Bétard; A. M. Kessling; M. Roy; A. Chamberland; S. Lussier-Cacan; J. D 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 786 KB

Familial hypercholesterolemia (FH), at a prevalence of about 1 in 200 in the French-Canadian population, is caused by a 10-kb deletion in the low-density lipoprotein (LDL) receptor gene in 60% of French-Canadian FH heterozygotes. We genotyped 159 FH patients who carry this common mutation and 221 he